# PHEXXI
> **NDA208352** · New Drug Application · Sponsor: EVOFEM INC · Approved 2020-05-22
## Drug
- **FDA Application Number:** NDA208352
- **Application type:** New Drug Application
- **Brand name:** PHEXXI
- **Generic name:** LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE
- **Active ingredients:** CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE
- **Dosage form:** GEL
- **Route:** VAGINAL
- **Marketing status:** Prescription
- **Sponsor:** EVOFEM INC
- **Manufacturer:** Evofem, Inc.
- **First approval:** 2020-05-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208352)
---
*AI Analytics · CC0 1.0*